Menu
Back to Journals » OncoTargets and Therapy » Volume 16
The Roles of Serum CXCL16 in Circulating Tregs and Gastrointestinal Stromal Tumor Cells [Retraction]
Received 6 July 2023
Accepted for publication 6 July 2023
Published 7 July 2023 Volume 2023:16 Pages 543—544
Xing Y, Zhang J, Xu H. Onco Targets Ther. 2016;9:3939–3949.
We, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. Concerns were raised following the authors request to correct images in Figure 3. It was found some of the images had been duplicated. Specifically,
- Images from Figure 3C, Migration, Treg-C+S and Migration, GIST882-sorafenib have been duplicated.
- Images from Figure 3C, Invasion, Treg and Migration, GIST-T1-sorafenib have been duplicated.
When approached for an explanation, the authors were cooperative but were unable to adequately address the concerns raised and could not provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors listed in this publication have been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This retraction relates to this paper
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.